DR. JONATHAN CALVIN WONG, PHARM.D.
Pharmacy in Palo Alto, CA

License number
California 62502
Category
Pharmacy
Type
Pharmacist
Address
Address 2
3801 Miranda Ave (119), Palo Alto, CA 94304
106 Summit St, San Francisco, CA 94132
Phone
(650) 493-5000
(650) 852-3444 (Fax)
(415) 286-6949

Professional information

Jonathan Wong Photo 1

Software Engineer - Independent Consulting

Position:
Software Engineer at Xoom Corporation, Software Engineer - Independent Consulting at Zelos Software
Location:
San Francisco Bay Area
Industry:
Computer Software
Work:
Xoom Corporation - san francisco since Feb 2013 - Software Engineer Zelos Software since Apr 2010 - Software Engineer - Independent Consulting Mercedes-Benz Research & Development North America, Inc. - Palo Alto, CA Apr 2010 - Jun 2012 - Systems Engineer RTZ Associates Jul 2009 - Apr 2010 - Software Development University of California Nov 2007 - Jun 2009 - Computer Technician and Server Administrator/Webmaster Apple Inc Jun 2008 - Dec 2008 - Apple Care - Technical Support Agent
Education:
University of California, Davis 2004 - 2009
Bachelor of Science (BS), Computer Science and Engineering
Languages:
Cantonese/Chinese, English


Jonathan Wong Photo 2

Risk Assurance Senior Associate At Pricewaterhousecoopers

Position:
Risk Assurance Senior Associate at PricewaterhouseCoopers
Location:
San Francisco, California
Industry:
Accounting
Work:
PricewaterhouseCoopers since Jul 2010 - Risk Assurance Senior Associate Santa Clara University Aug 2009 - Jun 2010 - Assistant Resident Director Santa Clara University - Santa Clara University Dec 2006 - Jun 2010 - CAAP Tutor and Mandarin Chinese Instructor PricewaterhouseCoopers Jun 2009 - Aug 2009 - Systems Process Assurance Intern
Education:
Santa Clara University 2006 - 2010
BS, Dual Major: Accounting and Information Systems
Punahou School 1993 - 2006
Honor & Awards:
Certified Information Systems Auditor, 2013 Certified Risk and Information Systems Controls, 2013 Presidential Scholarships, Academic and Community Involvement, 2009-2010 Senior Accounting Department Scholarship, 2009 Moss Adams Accounting Scholarship, 2008
Certifications:
Certified Information Systems Auditor, ISACA
Certified Risk and Information Systems Controls, ISACA


Jonathan Wong Photo 3

Associate District Manager At Adp

Position:
Associate District Manager at ADP
Location:
San Francisco, California
Industry:
Consumer Electronics
Work:
ADP - South San Francisco since Sep 2012 - Associate District Manager Eton Corporation Feb 2008 - Jun 2012 - Account Executive Sherwin Williams Jan 2008 - Nov 2008 - Assistant Manager
Education:
San Francisco State University 2001 - 2007
Business Management
Languages:
Cantonese


Jonathan Wong Photo 4

Jonathan Wong - San Francisco, CA

Work:
Judicci Inc
Mechanical Design Engineering Intern
Judicci Inc.
3D Designer / Manufacturer
Carnegie Mellon University
Resident Assistant
Oceans Aware - Mossel Bay, Western Cape
Intern
Goodman Group
Intern
Education:
Carnegie Mellon University - Pittsburgh, PA
BS in Mechanical Engineering
Carnegie Mellon University - Pittsburgh, PA
BS in Biomedical Engineering
Skills:
SolidWorks, AutoDesk, Matlab, Arduino, Product Development, Mandarin Chinese, Spanish


Jonathan Wong Photo 5

Senior Vice President, Senior Group Technology Manager, Union Bank, N.a.

Location:
San Francisco Bay Area
Industry:
Financial Services


Jonathan Wong Photo 6

Jonathan Wong

Location:
San Francisco Bay Area
Industry:
Biotechnology


Jonathan Wong Photo 7

Jonathan Wong

Location:
San Francisco Bay Area
Industry:
Financial Services


Jonathan Wong Photo 8

Ex Vivo And In Vivo Expression Of The Thrombomodulin Gene For The Treatment Of Cardiovascular And Peripheral Vascular Diseases

US Patent:
7713522, May 11, 2010
Filed:
Jul 28, 2008
Appl. No.:
12/219714
Inventors:
Lakshman R. Sehgal - Monarch Beach CA, US
Jonathan Wong - Palo Alto CA, US
Assignee:
BioVec, LLC - Chicago IL
International Classification:
A01N 63/00, A61K 39/325, A61K 31/715, C12H 15/86, C07H 21/04
US Classification:
424 936, 4242331, 514 44, 435456, 536 235, 536 241, 536 242
Abstract:
The present invention relates to methods and compositions for treatment of cardiovascular and peripheral vascular diseases using ex vivo and in vivo gene delivery technologies. One aspect of the present invention relates to a method for treating a vascular disease by introducing a DNA sequence encoding a TM protein or its variant into a segment of a blood vessel ex vivo using a gutless adenovirus vector. Another aspect of the present invention is to provide a gutless adenovirus vector carrying a transgene, such as a gene encoding TM protein or its variant.


Jonathan Wong Photo 9

Ex Vivo And In Vivo Expression Of The Thrombomodulin Gene For The Treatment Of Cardiovascular And Peripheral Vascular Diseases

US Patent:
7803365, Sep 28, 2010
Filed:
Mar 13, 2007
Appl. No.:
11/685474
Inventors:
Lakshman R. Sehgal - Monarch Beach CA, US
Jonathan Wong - Palo Alto CA, US
Assignee:
Biovec, LLC - Chicago IL
International Classification:
A01N 63/00, A61K 31/715, A61K 39/235, C07H 21/04, C12N 15/861
US Classification:
424 936, 4242331, 435456, 514 44, 536 235, 536 241, 536 242
Abstract:
The present invention relates to methods and compositions for treatment of cardiovascular and peripheral vascular diseases using ex vivo and in vivo gene delivery technologies. One aspect of the present invention relates to a method for treating a vascular disease by introducing a DNA sequence encoding a TM protein or its variant into a segment of a blood vessel in vivo using a gutless adenovirus vector. Another aspect of the present invention is to provide a method to deliver a gutless adenovirus vector carrying a DNA sequence encoding a TM protein or its variant using a stent.


Jonathan Wong Photo 10

In Vivo And Ex Vivo Gene Transfer Into Renal Tissue Using Gutless Adenovirus Vectors

US Patent:
2011030, Dec 15, 2011
Filed:
Jul 11, 2011
Appl. No.:
13/180378
Inventors:
Lakshman R. SEHGAL - Monarch Beach CA, US
Jonathan Wong - Palo Alto CA, US
Assignee:
BIOVEC, LLC - Chicago IL
International Classification:
A61F 2/04, A61M 25/10, A61P 9/10, A61P 9/12, A61K 31/711, A61P 13/12
US Classification:
623 2365, 514 44 R, 604509
Abstract:
A method for treating a renal disease in a subject is disclosed. The method includes administering into a kidney of the subject with an effective amount of a gutless adenoviral vector containing a polynucleotide encoding a therapeutic agent. The gutless adenoviral vector contains the nucleotide sequence of SEQ ID NO:13 or SEQ ID NO:15 and expresses the therapeutic agent in a kidney tissue of the subject.